These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30893303)

  • 1. Identification of pathways associated with chemosensitivity through network embedding.
    Wang S; Huang E; Cairns J; Peng J; Wang L; Sinha S
    PLoS Comput Biol; 2019 Mar; 15(3):e1006864. PubMed ID: 30893303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Pathway Coexpression Network: Revealing pathway relationships.
    Pita-Juárez Y; Altschuler G; Kariotis S; Wei W; Koler K; Green C; Tanzi RE; Hide W
    PLoS Comput Biol; 2018 Mar; 14(3):e1006042. PubMed ID: 29554099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A computational approach to identify cellular heterogeneity and tissue-specific gene regulatory networks.
    Jambusaria A; Klomp J; Hong Z; Rafii S; Dai Y; Malik AB; Rehman J
    BMC Bioinformatics; 2018 Jun; 19(1):217. PubMed ID: 29940845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of genes and pathways involved in kidney renal clear cell carcinoma.
    Yang W; Yoshigoe K; Qin X; Liu JS; Yang JY; Niemierko A; Deng Y; Liu Y; Dunker A; Chen Z; Wang L; Xu D; Arabnia HR; Tong W; Yang M
    BMC Bioinformatics; 2014; 15 Suppl 17(Suppl 17):S2. PubMed ID: 25559354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of selective cytotoxic and synthetic lethal drug responses in triple negative breast cancer cells.
    Gautam P; Karhinen L; Szwajda A; Jha SK; Yadav B; Aittokallio T; Wennerberg K
    Mol Cancer; 2016 May; 15(1):34. PubMed ID: 27165605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linking pathway gene expressions to the growth inhibition response from the National Cancer Institute's anticancer screen and drug mechanism of action.
    Huang R; Wallqvist A; Thanki N; Covell DG
    Pharmacogenomics J; 2005; 5(6):381-99. PubMed ID: 16103895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knowledge-guided gene prioritization reveals new insights into the mechanisms of chemoresistance.
    Emad A; Cairns J; Kalari KR; Wang L; Sinha S
    Genome Biol; 2017 Aug; 18(1):153. PubMed ID: 28800781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying epigenetically dysregulated pathways from pathway-pathway interaction networks.
    Visakh R; Abdul Nazeer KA
    Comput Biol Med; 2016 Sep; 76():160-7. PubMed ID: 27454244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DIFFERENTIAL PATHWAY DEPENDENCY DISCOVERY ASSOCIATED WITH DRUG RESPONSE ACROSS CANCER CELL LINES.
    Speyer G; Mahendra D; Tran HJ; Kiefer J; Schreiber SL; Clemons PA; Dhruv H; Berens M; Kim S
    Pac Symp Biocomput; 2017; 22():497-508. PubMed ID: 27897001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathway Network Analyses for Autism Reveal Multisystem Involvement, Major Overlaps with Other Diseases and Convergence upon MAPK and Calcium Signaling.
    Wen Y; Alshikho MJ; Herbert MR
    PLoS One; 2016; 11(4):e0153329. PubMed ID: 27055244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-acting gene networks predict TRAIL responsiveness of tumour cells with high accuracy.
    O'Reilly P; Ortutay C; Gernon G; O'Connell E; Seoighe C; Boyce S; Serrano L; Szegezdi E
    BMC Genomics; 2014 Dec; 15(1):1144. PubMed ID: 25527049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinformatic analysis linking genomic defects to chemosensitivity and mechanism of action.
    Covell DG
    PLoS One; 2021; 16(4):e0243336. PubMed ID: 33909629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying genes related to chemosensitivity using support vector machine.
    Bao L
    Methods Mol Med; 2005; 111():233-40. PubMed ID: 15911982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying drug active pathways from gene networks estimated by gene expression data.
    Tamada Y; Imoto S; Tashiro K; Kuhara S; Miyano S
    Genome Inform; 2005; 16(1):182-91. PubMed ID: 16362921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Use of Large-Scale Chemically-Induced Transcriptome Data Acquired from LINCS to Study Small Molecules.
    Iwata M; Yamanishi Y
    Methods Mol Biol; 2019; 1888():189-203. PubMed ID: 30519948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathway and Network Analysis of Differentially Expressed Genes in Transcriptomes.
    Huang Q; Sun MA; Yan P
    Methods Mol Biol; 2018; 1751():35-55. PubMed ID: 29508288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel dysregulated pathway-identification analysis based on global influence of within-pathway effects and crosstalk between pathways.
    Han J; Li C; Yang H; Xu Y; Zhang C; Ma J; Shi X; Liu W; Shang D; Yao Q; Zhang Y; Su F; Feng L; Li X
    J R Soc Interface; 2015 Jan; 12(102):20140937. PubMed ID: 25551156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathway-based Bayesian inference of drug-disease interactions.
    Pratanwanich N; Lió P
    Mol Biosyst; 2014 Jun; 10(6):1538-48. PubMed ID: 24695945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human disease network in terms of dysfunctional regulatory mechanisms.
    Yang J; Wu SJ; Dai WT; Li YX; Li YY
    Biol Direct; 2015 Oct; 10():60. PubMed ID: 26450611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression profiling of epithelial ovarian cancer reveals key genes and pathways associated with chemotherapy resistance.
    Zhang M; Luo SC
    Genet Mol Res; 2016 Jan; 15(1):. PubMed ID: 26909918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.